(Updated - December 20, 2022 6:02 AM EST)

Jefferies analyst Akash Tewar upgraded Zymeworks (NASDAQ: ZYME) from Hold to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE